Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_assertion type Assertion NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_head.
- NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_assertion description "[The frequency of TAP1, LMP2 and tapasin loss varied between 33% of primary adenocarcinomas, 40% of HIN to approximately 67% of metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_provenance.
- NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_assertion evidence source_evidence_literature NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_provenance.
- NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_assertion SIO_000772 14750179 NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_provenance.
- NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_assertion wasDerivedFrom befree-20150227 NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_provenance.
- NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_assertion wasGeneratedBy ECO_0000203 NP874790.RA70A7mz5vN6PyVGi85laOv5gGI0FHB6J7AX2czo9C43o130_provenance.